Novavax spikes 67% after UK study shows its COVID-19 vaccine is 89% effective
Shares of Novavax soared more than 2,700% since the company advanced the development of its novel COVID-19 vaccine candidate in late February of 2020.
Full Article
Novavax spikes 67% after UK study shows its COVID-19 vaccine is 89% effective
Business Insider
0 shares
2 views
You might like
Related news coverage
Novavax Covid vaccine news welcomed in South Africa
IndiaTimes
Early findings from a British study suggest the vaccine is nearly 96% effective against the older coronavirus and nearly 86%..
-
News24.com | Covid-19 vaccines may need adjusting to new strains, scientists say
News24
-
Novavax’s Covid-19 vaccine nearly 90% effective in U.K. study, much less in South Africa
bizjournals
-
Novavax COVID-19 Vaccine Works, But Less So Against Variants
VOA News
-
Coronavirus Vaccine From Novavax Is 89.3% Effective
Motley Fool
Advertisement
More coverage
Novavax COVID-19 Vaccine Effective, But Less So Against Variant In South Africa
NPR
Novavax says its COVID-19 vaccine is 89% effective at preventing illness, according to an interim analysis of a U.K. study. But the..
-
Novavax vaccine is 98% effective against COVID-19 in U.K. study
CBS News
-
Novavax COVID-19 vaccine works, but less so against variants
SeattlePI.com
-
Novavax COVID-19 vaccine works, but less so against variants
Upworthy
-
Novavax COVID-19 vaccine demonstrates 89.3% efficacy in UK phase 3 trial
Jerusalem Post